MedTrace Logo

Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg

NCT04868409 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-03-19

No results posted yet for this study

Summary

The aim of this study is to determine the proportion of excellent tracheal intubation conditions at 60 seconds after administration of either rocuronium 1.0 mg/kg or suxamethonium 1 mg/kg in patients with age ≥ 80 years during rapid sequence induction.

Conditions

  • Intubation Conditions

Interventions

DRUG

Suxamethonium

1 mg/kg for tracheal intubation after 60 seconds

DRUG

Rocuronium

1 mg/kg for tracheal intubation after 60 seconds

Sponsors & Collaborators

  • Matias Vested

    lead OTHER

Principal Investigators

  • Lars S Rasmussen · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2024-03-14
Completion
2024-03-17

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868409 on ClinicalTrials.gov